Angioedema

ViroPharma Incorporated Reports Second Quarter 2009 Financial Results

... our product used to prevent attacks of hereditary angioedema (HAE) - exceeding our initial expectations, the ... [human]) for routine prophylaxis against angioedema attacks in adolescent and adult patients with hereditary angioedema (HAE), also known as C1 inhibitor deficiency (for ...

New Directions in Angioedema: A Focus on Etiologies and Clinical Approach

... VOORHEES, N.J., June 10 /PRNewswire/ -- angioedema is a clinical syndrome characterized by ... swelling. Diagnosing the underlying cause of angioedema can be challenging, as there are multiple ... newsletter series titled New Directions in angioedema . The second issue of this three-part newsletter ...

New Directions in Angioedema: A Focus on Pathogenesis and Classification

... management of patients with urticaria (hives) and angioedema can be challenging, as both disorders can be ... by the seemingly identical presentation of angioedema subtypes. It is important that healthcare professionals who treat angioedema and urticaria understand the pathophysiology of ...

ViroPharma to Host Investor 'Teach-In' Educational Symposium on Hereditary Angioedema

... - Hereditary angioedema (HAE) and the Dawn of New Therapeutics - ... educational event for investors on Hereditary angioedema (HAE), on Tuesday, March 10, 2009. Lectures will ... president, respectively, of the U.S. Hereditary angioedema Association (HAEA), and Aleena Banerji , M.D., ...

ViroPharma Submits Supplemental Biologics License Application for Cinryze(TM) to Treat Acute Attacks of Hereditary Angioedema

... as a treatment for acute attacks of hereditary angioedema (HAE). The sBLA is based on a re-analysis ... acute treatment and routine prophylaxis against angioedema attacks. The Phase 3 acute treatment ... HAE attacks. "Routine prophylaxis against angioedema attacks is beneficial for many HAE patients, and ...

ViroPharma Incorporated Reports Third Quarter 2008 Financial Results

... important drug to prevent attacks of hereditary angioedema in a population with few treatment options." ... (human)) for routine prophylaxis against angioedema attacks in adolescent and adult patients with hereditary angioedema (HAE), also known as C1 inhibitor deficiency (for ...

ViroPharma Announces Initiation Of Non-Toxigenic Clostridium Difficile Phase 1 Program

... (C1 esterase inhibitor [human]) for routine prophylaxis against angioedema attacks in adolescent and adult patients with hereditary angioedema (HAE), also known as C1 inhibitor deficiency (for prescribing information ...

ViroPharma Announces Support by Advisory Committee of The Office of Generic Drugs Proposed Guidelines for Developing Generic Versions of Oral Vancomycin Hydorchloride

... (C1 esterase inhibitor (human)) for routine prophylaxis against angioedema attacks in adolescent and adult patients with hereditary angioedema (HAE), also known as C1 inhibitor deficiency (for prescribing information ...

ViroPharma to Release 2009 Second Quarter Financial Results on July 29, 2009

... (C1 esterase inhibitor (human)) for routine prophylaxis against angioedema attacks in adolescent and adult patients with hereditary angioedema (HAE), also known as C1 inhibitor deficiency (for prescribing information ...

ViroPharma Announces Appointment of Frank Baldino, Jr., Ph.D. to Board of Directors

... (C1 esterase inhibitor (human)) for routine prophylaxis against angioedema attacks in adolescent and adult patients with hereditary angioedema (HAE), also known as C1 inhibitor deficiency (for prescribing information ...

Angioedema in Medical Technology

Scientific Data Relating to Cinryze(TM) Presented at 6th Annual C1 Inhibitor Deficiency Workshop

... 2008 for routine prophylaxis against hereditary angioedema (HAE) attacks in adults and adolescents. In ... Prophylactic Therapy Considerations in Hereditary angioedema In an abstract entitled, 'When ... Inhibitor as Therapy for Swelling in Hereditary angioedema Patients Reverses Abnormalities of the Plasma ...

FDA Grants Priority Review of a Supplemental Biologics License Application for Cinryze(TM) C1 Inhibitor (Human) as Treatment for Acute Attacks of Hereditary Angioedema (HAE)

... as a treatment for acute attacks of Hereditary angioedema (HAE). The supplemental Biologics License ... October 10, 2008 for routine prophylaxis against angioedema attacks in adolescent and adult patients with ... the use of Cinryze for routine prophylaxis of angioedema attacks in patients with HAE, the currently ...

ViroPharma Announces Presentation of Cinryze(TM) Data in Acute Treatment of Hereditary Angioedema

... treated all types of acute hereditary angioedema (HAE) attacks seen in the study through the date ... injections of Cinryze for acute attacks of angioedema occurring at any anatomical site. Subjects could ... approved by FDA for routine prophylaxis against angioedema attacks in adolescent and adult patients with ....

ViroPharma Incorporated Completes Acquisition of Lev Pharmaceuticals

... Exclusivity for Prophylaxis against Hereditary angioedema - EXTON, Pa., Oct. 21 /PRNewswire-FirstCall/ -- ... for routine prophylaxis against angioedema attacks in adolescent and adult patients with hereditary angioedema (HAE). Hereditary angioedema, or C1 esterase ...

Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent

... price of EUR328 million adding hereditary angioedema (HAE) product, FIRAZYR(R), to its Human Genetic ... for the symptomatic treatment of acute attacks of angioedema by the European Medicines Agency (EMEA) and the ... in a pre-filled syringe. About Hereditary angioedema (HAE) HAE is a debilitating and potentially ...

ViroPharma Submits Comments on Vancocin(R) Draft Bioequivalence Guidance

... and Cinryze(TM) (C1 inhibitor (human)) for routine prophylaxis against angioedema attacks in adolescent and adult patients with hereditary angioedema (HAE), also known as C1 inhibitor deficiency (for prescribing information ...

ViroPharma Announces Discontinuation of Maribavir Phase 3 Study in Liver Transplant Patients

... and Cinryze(TM) (C1 inhibitor (human)) for routine prophylaxis against angioedema attacks in adolescent and adult patients with hereditary angioedema (HAE), also known as C1 inhibitor deficiency (for prescribing information ...

Changing Paradigms in Hereditary Angioedema: A Focus on Prompt Diagnosis and New Therapies

... Complimentary Continuing Education Lecture for Healthcare Professionals VOORHEES, N.J., March 17 /PRNewswire/ -- Hereditary angioedema (HAE) is estimated to afflict 10,000 people in the United States each year. Patients with HAE suffer from recurrent attacks of intense localized ...

Video: Zometa(R) Reduces Risk of Breast Cancer Recurrence in Premenopausal Women, Study in The New England Journal of Medicine Reports

... or other bisphosphonates, or any of the excipients in the formulation of Zometa. Hypersensitivity reactions, including rare cases of urticaria and angioedema and very rare cases of anaphylactic reaction/shock, have been reported. Due to the risk of clinically significant deterioration in renal ...

More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies

... or other bisphosphonates, or any of the excipients in the formulation of Zometa. Hypersensitivity reactions, including rare cases of urticaria and angioedema and very rare cases of anaphylactic reaction/shock, have been reported. Due to the risk of clinically significant deterioration in renal ...

Angioedema in Medical Dictionary

Angioedema

... angioedema , hereditary: A genetic form of angioedema . ( angioedema is also referred to as Quinke's disease .) ...

Hereditary angioedema

... Hereditary angioedema is an inherited disorder. It is caused by low ... in turn, affects blood vessels. Hereditary angioedema Hereditary Copro porphyria ( Porphyria ) ... Hereditary angioneurotic edema (or hereditary angioedema ) is a genetic form of ...

Anaphylaxis

... allergic reaction distinguished by the sudden onset of hives or angioedema , respiratory di stress , and a drop in blood pressure . ... range from dermatitis , conjunctivitis , rhinitis , urticaria , and angioedema to asthma and anaphylaxis . Severe latex sensitivity and its sequelae ...

Skin Diseases

... s, and skin , ... Allergic skin diseases such as urticaria and angioedema as well as atopic dermatitis are not clearly defined as true allergic disease s. Urticaria and angioedema are both due to excessive mast cell activity in the skin . The ...

Urticaria

... range from dermatitis , conjunctivitis , rhinitis , urticaria , and angioedema to asthma and anaphylaxis . Severe latex sensitivity and its sequelae ... taking of nickel salts in adults suffering from chronic urticaria or angioedema , ... ...

Angina pectoris

... Gale Encyclopedia of Medicine, Published December, 2002 by the Gale Group ... Angina Pectoris ( Angina ) Angio dysplasia of the Colon angioedema Angiofibroma - Juvenile (Juvenile Angiofibroma) Angioma - Cherry ( Cherry Angioma ) ... Angina pectoris Preliminary studies report reductions ...

Asthma

... ), ... Reactions to latex products may be localized or systemic and range from dermatitis , conjunctivitis , rhinitis , urticaria , and angioedema to asthma and anaphylaxis . Severe latex sensitivity and its sequelae have profound and lethal implications. A substance that is used to ...

Conjunctivitis

... ... Reactions to latex products may be localized or systemic and range from dermatitis , conjunctivitis , rhinitis , urticaria , and angioedema to asthma and anaphylaxis . Severe latex sensitivity and its sequelae have profound and lethal implications. The first symptoms include ...

Contact dermatitis

... (Nasal Allergies ) Allergic Rhino sinusitis (Nasal Allergies ) Allergic Conjunctivitis ... Dermatologic reactions include urticaria , angioedema , dermatitis (allergic contact dermatitis , photo dermatitis , exfoliative dermatitis ), fixed drug eruption, ... They usually develop ...

Dermatitis

... ivy . Reactions to latex products may be localized or systemic and range from dermatitis , conjunctivitis , rhinitis , urticaria , and angioedema to asthma and anaphylaxis . Severe latex sensitivity and its sequelae have profound and lethal implications. These include chronic ...

More>>

Angioedema in Biological Technology

ViroPharma Receives Complete Response Letter for Cinryze(TM) Supplemental Biologics License Application for Acute Treatment of Hereditary Angioedema

... as a treatment for acute attacks of hereditary angioedema (HAE). The FDA has requested an additional ... targeted therapy for routine prophylaxis against angioedema attacks. In clinical studies and in commercial ... of the U.S. and International Hereditary angioedema Association. "Cinryze as a prophylactic ...

ViroPharma Incorporated Honored by the National Organization for Rare Disorders

... for a rare and devastating disorder -- hereditary angioedema (HAE). HAE is a rare, severely debilitating, ... approved by FDA for routine prophylaxis against angioedema attacks in adolescent and adult patients with ... every 3 or 4 days for routine prophylaxis against angioedema attacks in HAE patients. Cinryze is administered ...

ViroPharma Incorporated Reports Fourth Quarter and Full Year 2008 Financial Results

... of Cinryze for routine prophylaxis of hereditary angioedema (HAE); Developed and successfully ... (human)) for routine prophylaxis against angioedema attacks in adolescent and adult patients with hereditary angioedema (HAE), also known as C1 inhibitor deficiency (for ...

ViroPharma to Present at Two June Healthcare Conferences

... (C1 esterase inhibitor (human)) for routine prophylaxis against angioedema attacks in adolescent and adult patients with hereditary angioedema (HAE), also known as C1 inhibitor deficiency (for prescribing information ...

ViroPharma Incorporated Reports First Quarter 2009 Financial Results

... (C1 esterase inhibitor (human)) for routine prophylaxis against angioedema attacks in adolescent and adult patients with hereditary angioedema (HAE), also known as C1 inhibitor deficiency (for prescribing information ...

ViroPharma to Release 2009 First Quarter Financial Results on April 29, 2009

... and Cinryze(TM) (C1 inhibitor (human)) for routine prophylaxis against angioedema attacks in adolescent and adult patients with hereditary angioedema (HAE), also known as C1 inhibitor deficiency (for prescribing information ...

Publication of Shire plc's Annual Report 2008

... Pharmaceuticals area. Human Genetic Therapies Treatments for angioedema FIRAZYR for hereditary angioedema ('HAE') in the US FIRAZYR is a treatment for acute HAE which Shire ...

ViroPharma Improves Financial Position Through Repurchase of $45 Million Principal Amount of Senior Convertible Notes

... and Cinryze(TM) (C1 inhibitor (human)) for routine prophylaxis against angioedema attacks in adolescent and adult patients with hereditary angioedema (HAE), also known as C1 inhibitor deficiency (for prescribing information ...

ViroPharma To Acquire Lev Pharmaceuticals

... Adds Late Stage Product Targeting Life-threatening Hereditary angioedema Disease with Limited Treatment Options - - Company to Host Conference ... Drug Administration as a replacement therapy for patients with hereditary angioedema (HAE), also known as C1 esterase inhibitor (C1-INH) deficiency. The use of ...

Shire plc: Core Portfolio of Products Delivers 20% Sales Growth

... of charge initially, in order to provide access to patients as quickly as possible. FIRAZYR(R) - for the treatment of hereditary angioedema ("HAE") - In June 2009, Shire initiated a Phase 3 study in patients with acute attacks of HAE, known as the FAST-3 trial, which is designed to ...